✦ LIBER ✦

HEPATECTOMY FOR METASTATIC NONCOLORECTAL GASTROINTESTINAL, BREAST AND TESTICULAR TUMOURS

✍ Scribed by Matthew S. Metcalfe; Emma J. Mullin; Guy J. Maddern

Book ID: 108995158
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 64 KB
Volume: 76
Category: Article
ISSN: 1445-1433
DOI: 10.1111/j.1445-2197.2006.03689.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic resection for metastatic gastroi

Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors

✍ D. GOMEZ; H.Z. MALIK; A. AL-MUKTHAR; KV. MENON; G.J. TOOGOOD; J.P.A. LODGE; Mr K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Effect of loss of heterozygosity of the

Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors

✍ Hirotoshi Kikuchi; Masayoshi Yamamoto; Yoshihiro Hiramatsu; Megumi Baba; Manabu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

An observation of DNA ploidy, histologic

An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma

✍ Dr. Andrew Hitchcock; Ian O. Ellis; John F. R. Robertson; Alan Gilmour; Jane Bel 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB 👁 1 views

A cohort of 36 cases of advanced breast carcinoma were included in the study. DNA ploidy, histological grade, and immunoreactivity for carcino-embryonic antigen (CEA), carcino-embryonic antigen with normal cross-reacting antigen (CEA/NCA), and to NCRC-11 were assessed in primary breast carcinomas an

637 Evaluation of spontaneous apoptosis

637 Evaluation of spontaneous apoptosis and BCL-2, BAX, MCL-1 expressions for prognostic value in metastatic testicular germ cell tumour tissues

✍ S. Oner; M. Gunay; S. Eskicorapci; F. Cakmak; H. Ozen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Phase II trial of docetaxel and Hercepti

Phase II trial of docetaxel and Herceptin (R) as first- or second-line chemotherapy for women with metastatic breast cancer whose tumours overexpress HER2

✍ Burris, H.A.; Hainesworth, J.D.; Albain, K.; Huntington, M.; Greco, F.A.; Erland 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 170 KB

5021 POSTER DISCUSSION Multivariable Pro

5021 POSTER DISCUSSION Multivariable Prognostic Model for Individual Survival Prediction of Metastatic Breast Cancer Patients Taking Into Account Circulating Tumour Cells (CTC) Count Before and During Chemotherapy

✍ Bidard, F.; Hajage, D.; Bachelot, T.; Delaloge, S.; Brain, E.; Campone, M.; Dier 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB